John Scales Centre for Biomedical Engineering, Institute of Orthopaedics and Musculoskeletal Science, Division of Surgery and Interventional Science, University College London, Royal National Orthopaedic Hospital Trust, Middlesex, UK.
Shoulder and Elbow Service, Royal National Orthopaedic Hospital, Stanmore, UK.
Orthop J Sports Med. 2015 Jun 10;3(6):2325967115587495. doi: 10.1177/2325967115587495. eCollection 2015 Jun.
Tears of the rotator cuff are one of the most common tendon disorders. Treatment often includes surgical repair, but the rate of failure to gain or maintain healing has been reported to be as high as 94%. This has been substantially attributed to the inadequate capacity of tendon to heal once damaged, particularly to bone at the enthesis. A number of strategies have been developed to improve tendon-bone healing, tendon-tendon healing, and tendon regeneration. Scaffolds have received considerable attention for replacement, reconstruction, or reinforcement of tendon defects but may not possess situation-specific or durable mechanical and biological characteristics.
To provide an overview of the biology of tendon-bone healing and the current scaffolds used to augment rotator cuff repairs.
Systematic review; Level of evidence, 4.
A preliminary literature search of MEDLINE and Embase databases was performed using the terms rotator cuff scaffolds, rotator cuff augmentation, allografts for rotator cuff repair, xenografts for rotator cuff repair, and synthetic grafts for rotator cuff repair.
The search identified 438 unique articles. Of these, 214 articles were irrelevant to the topic and were therefore excluded. This left a total of 224 studies that were suitable for analysis.
A number of novel biomaterials have been developed into biologically and mechanically favorable scaffolds. Few clinical trials have examined their effect on tendon-bone healing in well-designed, long-term follow-up studies with appropriate control groups. While there is still considerable work to be done before scaffolds are introduced into routine clinical practice, there does appear to be a clear indication for their use as an interpositional graft for large and massive retracted rotator cuff tears and when repairing a poor-quality degenerative tendon.
肩袖撕裂是最常见的肌腱疾病之一。治疗通常包括手术修复,但据报道,愈合失败的比例高达 94%。这主要归因于肌腱一旦受损,尤其是在腱骨结合处,愈合能力不足。已经开发了许多策略来改善肌腱-骨愈合、肌腱-肌腱愈合和肌腱再生。支架在肌腱缺损的替代、重建或加固方面受到了广泛关注,但可能不具备特定于情况或持久的机械和生物学特性。
提供肩袖肌腱-骨愈合的生物学概述以及目前用于增强肩袖修复的支架。
系统评价;证据水平,4 级。
使用术语肩袖支架、肩袖增强、用于肩袖修复的同种异体移植物、用于肩袖修复的异种移植物和用于肩袖修复的合成移植物,对 MEDLINE 和 Embase 数据库进行了初步文献检索。
搜索共确定了 438 篇独特的文章。其中,214 篇与主题无关,因此被排除。这剩下了总共 224 篇适合分析的文章。
已经开发了许多新型生物材料制成具有生物和机械优势的支架。很少有临床试验在设计良好、长期随访且有适当对照组的研究中检查它们对肌腱-骨愈合的影响。虽然在将支架引入常规临床实践之前还有很多工作要做,但似乎有明确的迹象表明它们可作为大型和巨大回缩肩袖撕裂以及修复质量较差的退行性肌腱的中间移植物使用。